β¨ Health Notices
NEW ZEALAND GAZETTE
No. 153
Health
Burial and Cremation Act 1964
Removal of Monuments and Tablets, Baptist Burial Ground, Rangiora
I, Ruth Dyson, Associate Minister of Health, authorise, under section 45 (1) of the Burial and Cremation Act 1964, the removal of the following monuments and tablets in the denominational burial ground known as Baptist Burial Ground, Rangiora:
Description of Tablets and Monuments:
(a) Anne Lizabeth Good, died 1 May 1906.
(b) Edward Good, died 6 December 1875.
(c) Samuel John Delabere Good, died 15 February 1928.
The tablets and monuments described above are all located within an 18 square metre area in the south-west corner approximately 9 metres from the eastern boundary and 2 metres from the southern boundary of the Baptist Burial Ground, Rangiora.
Dated at Wellington this 31st day of October 2001.
RUTH DYSON, Associate Minister of Health.
go7916
Medicines Act 1981
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Herceptin
Active Ingredient(s):
Trastuzumab 440mg
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer(s):
F Hoffmann-La Roche AG, Basel, Switzerland
Genentech Inc, South San Francisco, California, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 31st day of October 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go7825
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
CAPD/DPCA 10 Sleep Safe
Active Ingredient(s):
Calcium chloride (dihydrate) 0.147g/L
Glucose monohydrate 16.5g/L equivalent glucose anhydrous 15g/L
Magnesium chloride (hexahydrate) 0.1017g/L
Sodium chloride 5.786g/L
Sodium lactate 3.925g/L
Dosage Form:
Dialysis solution
New Zealand Sponsor:
Fresenius Medical Care New Zealand
Manufacturer(s):
Fresenius Medical Care Deutschland GmbH, St Wendel, Saarland, Germany
Product:
CAPD/DPCA 11 Sleep Safe
Active Ingredient(s):
Calcium chloride (dihydrate) 0.147g/L
Glucose monohydrate 46.75g/L equivalent glucose anhydrous 42.5g/L
Magnesium chloride (hexahydrate) 0.1017g/L
Sodium chloride 5.786g/L
Sodium lactate 3.925g/L
Dosage Form:
Dialysis solution
New Zealand Sponsor:
Fresenius Medical Care New Zealand
Manufacturer(s):
Fresenius Medical Care Deutschland GmbH, St Wendel, Saarland, Germany
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 153
Gazette.govt.nz —
NZ Gazette 2001, No 153
β¨ LLM interpretation of page content
π₯ Removal of Monuments and Tablets, Baptist Burial Ground, Rangiora
π₯ Health & Social Welfare31 October 2001
Burial and Cremation Act 1964, Monuments, Tablets, Baptist Burial Ground, Rangiora
- Anne Lizabeth Good, Deceased, monument to be removed
- Edward Good, Deceased, monument to be removed
- Samuel John Delabere Good, Deceased, monument to be removed
- Ruth Dyson, Associate Minister of Health
π₯ Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare31 October 2001
Medicines Act 1981, Provisional Consent, Herceptin, Trastuzumab, Roche Products (New Zealand) Limited
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare31 October 2001
Medicines Act 1981, Consent, CAPD/DPCA 10 Sleep Safe, CAPD/DPCA 11 Sleep Safe, Fresenius Medical Care New Zealand